MedPath

Albuvirtide

Generic Name
Albuvirtide
Drug Type
Biotech
CAS Number
1417179-66-8
Unique Ingredient Identifier
MG9PC54E43

Overview

Albuvirtide is under investigation in clinical trial NCT03719664 (Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects).

Background

Albuvirtide is under investigation in clinical trial NCT03719664 (Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects).

Indication

适用于与其它抗反转录病毒药物联合使用,治疗已接受过抗病毒药物治疗的HIV-1感染者。

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath